# Menopause Hormone Therapy When Your Heart Is at Risk: What the 2026 Guidelines Say **By Paula Gallagher** · 2026-10-29 ![Photograph illustrating Menopause Hormone Therapy When Your Heart Is at Risk](https://cdn.shopify.com/s/files/1/0319/0960/9603/files/hero-4362d61f-900x600.png?v=1793028774&width=300&height=200&crop=center) Lately we've been getting questions about menopause hormone therapy vs hormone replacement therapy, especially from women told their heart was too risky for either. Here's the news. A 2026 joint position statement from FIGO and the World Heart Federation swapped the old blanket "no" for individual risk assessment and personalized treatment. That means high blood pressure, high cholesterol, or diabetes no longer close the door automatically. For women at higher cardiovascular or clot risk, the preferred path is low-dose transdermal estrogen, a patch, gel, or spray, with micronized progesterone added for women who have a uterus. Whether it's right for you still depends on your numbers, your history, and a real conversation with your doctor. If you were previously told MHT was off the table due to high blood pressure, high cholesterol, diabetes or any other heart risk factor, that’s not necessarily true today. In a 2026 joint position statement, the International Federation of Gynecology and Obstetrics (FIGO) and the World Heart Federation (WHF) advise that MHT should no longer be automatically contraindicated in such patients, but rather evaluated based on each person’s risk factors and tailored accordingly. For women who are at high risk of heart disease or blood clots, the recommendation is low-dose transdermal estrogen (a patch, gel, or spray), and to add micronized progesterone for women who have a uterus. Is hormone therapy safe in menopause? The answer lies in your numbers, your history, and the type of therapy, so talk to your doctor. This guide covers the new guidelines, types of menopause hormone therapy, dose, benefits and risks, cancer and breast cancer risk, timing and age, and natural alternatives like herbs. ## What Menopause Hormone Therapy Really Is ![Three photo panels showing oral tablet, transdermal patch, and micronized progesterone capsule forms](https://cdn.shopify.com/s/files/1/0319/0960/9603/files/slot-body-1-8156c80e.png?v=1793028762) Menopause hormone therapy, often shortened to MHT, is a treatment that replaces the estrogen your ovaries produce less of during the menopause transition. For women with a uterus, a progestogen is added to protect the uterine lining. MHT treatment is used for hot flashes, night sweats, trouble sleeping, and vaginal changes. Among the benefits of menopause hormone therapy, symptom relief is the best established. It's the shape you do it in that counts. Estrogen is available in oral tablet form, as well as in patch form, gel and spray form. Progesterone is available in capsule form or in some combination patches. The route and dose of your prescription determines how the hormone enters your body. - **Oral estrogen:** swallowed, passes through the liver first - Transdermal estrogen: a patch, gel, or spray that's put on the skin so it can be absorbed - **Micronized progesterone:** a capsule often taken at bedtime ## Menopause Hormone Therapy vs. Hormone Replacement Therapy What's the difference between menopause hormone therapy and hormone replacement therapy? Not much. Clinicians now prefer the more accurate term MHT (menopause hormone therapy), while HRT remains the common everyday name, so "menopause hormone therapy vs HRT" is largely a difference in vocabulary. The shift in language reflects a shift in thinking. Modern care is less about replacing everything and more about using the lowest effective dose, in the right form, for your situation. ## When Your Heart Carries Extra Risk If you have high blood pressure, diabetes, or high cholesterol, the form of estrogen delivery is important. For women with higher cardiovascular risk or clotting risk, the paper recommends the use of transdermal estradiol (a patch, gel, or spray), rather than oral tablets. Transdermal estrogen is not passed through the liver first, and this is associated with a lower risk of blood clots compared to swallowed estrogen. Micronized progesterone is used in women who still have a uterus. This is the combination the position paper now recommends for women with those risks. At intermediate risk for heart disease, a coronary artery calcium scan can help determine your risk level with greater accuracy. A score of 10 or less can categorize you as low risk, which may allow you access to treatment options that were unavailable to you before. However you proceed, your blood pressure, cholesterol, and blood sugar need ongoing attention. Hormone therapy won't manage them for you, and this applies whether you're considering menopause hormone therapy and diabetes, cholesterol, or hypertension. An important caveat: the position statement addresses heart risk factors only. It doesn't change recommendations for people with a history of stroke, breast cancer, or unexplained bleeding, and it isn't a call to use hormone therapy to prevent heart disease. - **Higher clot risk:** low-dose transdermal estradiol is preferred over oral - **Intermediate risk:** a calcium score of 10 or below may reclassify you as low risk - **Everyone:** keep managing your blood pressure, cholesterol, and blood glucose ## Why Timing and Age Shift the Picture ![Timeline of three age windows illustrating the menopause hormone therapy timing hypothesis](https://cdn.shopify.com/s/files/1/0319/0960/9603/files/slot-body-2-285280b9.png?v=1793028764) Age at the start matters. Research on menopause hormone therapy after 60 and after 65 generally shows a less favorable balance than starting closer to menopause. This is often called the "timing hypothesis." It is generally considered to hold for most women who start treatment within 10 years of menopause or before age 60. The same timing question comes up in the research on menopause hormone therapy and dementia and on stroke risk, which is why starting age, and when to stop menopause hormone therapy, belongs in every conversation about the benefits and risks. A 2024 systematic review and meta-analysis, echoed in later menopause hormone therapy 2025 discussions, examined hormone therapy and the cardiovascular system in postmenopausal women. It underscored that route, dose, and timing all shape the outcome. Your decision should rest on your own numbers and a conversation with your clinician, and [**a lab review consultation**](https://www.myvillanegreen.com/pages/appointment-for-your-lab-review-consultation "https://www.myvillanegreen.com/pages/appointment-for-your-lab-review-consultation") can help you walk through them. ## Weighing the Cancer and Breast Cancer Questions Do you have to worry about cancer when taking menopause hormone therapy? The risk for breast cancer increased slightly in the Women's Health Initiative trial of estrogen plus progestin during the years of taking this regimen. You may want to use a menopause hormone therapy risk calculator to get a preliminary idea, but keep in mind that breast cancer risk depends on the kinds of hormones, the duration of use, and your health history. Estrogen-alone and estrogen-plus-progestogen regimens have different risks, and newer menopause hormone therapy FDA-reviewed formulations such as micronized progesterone are still being studied. Menopause hormone therapy and cancer risk isn't one flat number. This guidance does not apply to you if you have had breast cancer, or have any questions about menopause hormone therapy and endometriosis, and you should speak to your oncology and menopause team instead. ## Natural and Herbal Paths to Consider ![Natural and Herbal Paths to Consider](https://cdn.shopify.com/s/files/1/0319/0960/9603/files/asset-1793028431268.png?v=1793028769) Other women seek out natural and alternative options to menopause, either in conjunction with therapy or prior to considering it. Herbs and other alternative remedies have been studied as treatments for menopause symptoms, but their effects are inconsistent and marginal. If heart numbers are part of your picture, targeted nutrition may help support the metrics your clinician is tracking. [**Berberine**](https://myvillanegreen.com/products/thorne-berberine-500-60-capsules "https://myvillanegreen.com/products/thorne-berberine-500-60-capsules") and Cinnamon are often discussed for blood sugar support, and ingredients in [**Cholesterol Support**](https://myvillanegreen.com/products/cholesterol-support "https://myvillanegreen.com/products/cholesterol-support") are studied for lipid metabolism. You can [browse our **herbs collection**](https://www.myvillanegreen.com/collections/herbs "https://www.myvillanegreen.com/collections/herbs") and talk with us about what fits your routine. They're just part of your wellness regimen. They're not a replacement for hormone replacement therapy or the drugs you take to control your blood pressure, cholesterol, and blood sugar levels. - [**Berberine**](https://myvillanegreen.com/products/berberine-500mg-787500070138 "https://myvillanegreen.com/products/berberine-500mg-787500070138") is blood sugar and metabolic support - [**Cinnamon 250 Mg**](https://myvillanegreen.com/products/cinnamon-250-mg "https://myvillanegreen.com/products/cinnamon-250-mg")**:** traditionally used alongside glucose-friendly habits - [**Cholesterol Support**](https://myvillanegreen.com/products/cholesterol-support "https://myvillanegreen.com/products/cholesterol-support")**:** designed to support healthy lipid levels ## Key Takeaways - Instead of a blanket "no," the new FIGO and World Heart Federation guidelines call for a "yes" tailored to each patient's cardiac risk profile. - For patients with a higher risk of cardiovascular disease or clots, transdermal estradiol (in low dose) in combination with micronized progesterone is preferred. - A coronary artery calcium score of 10 or below can reclassify intermediate-risk women as low risk. - Hormone treatment goes hand in hand with managing blood pressure, cholesterol, and blood sugar. - This information does not alter the benefits and harms of cardiovascular disease prevention in relation to stroke, breast cancer, and unrecognized bleeding. ## Frequently Asked Questions ### Does menopause hormone therapy cause cancer? Menopause hormone therapy and cancer risk isn't one flat number. In the Women's Health Initiative trial of estrogen plus progestin, breast cancer risk increased slightly during the years of use. Estrogen-alone and estrogen-plus-progestogen regimens carry different risks, and newer formulations such as micronized progesterone are still being studied. Breast cancer risk depends on the kinds of hormones, the duration of use, and your health history, so discuss your own risk factors with your doctor. ### Can menopause hormone therapy cause hair loss? It's not uncommon for women to experience hair changes through the menopause transition due to changing hormone levels. Menopause hormone therapy doesn't affect all women the same way. Some report less hair loss and stronger hair growth, while others experience increased shedding. If you're unhappy with hair loss, speak to your health care provider. They can look for other causes, such as a thyroid or iron deficiency. ### How does menopause hormone therapy work? Menopause hormone therapy replaces the estrogen your ovaries produce less of during the menopause transition, which helps with hot flashes, night sweats, sleep problems, and vaginal changes. For women with a uterus, a progestogen such as micronized progesterone is added to protect the uterine lining. It comes in oral and transdermal forms. The route and dose of your prescription determines how the hormone enters your body, so ask your doctor which form might be best. ### Does menopause hormone therapy prevent alzheimer's disease and dementia? Menopause hormone therapy is not a way to guard against Alzheimer's disease or dementia, and the FIGO and WHF position statement is not a call to use it for that purpose. The research on hormone therapy and dementia comes back to the timing hypothesis, where starting age shapes the balance of benefits and risks. Whether MHT fits you depends on your own numbers and history, so talk through it with your doctor. **Tags:** guidelines menopause hormone therapy, menopause hormone therapy 2026, menopause hormone therapy and cancer risk, menopause hormone therapy cancer risk, menopause hormone therapy risk calculator, menopause hormone therapy vs hormone replacement therapy --- > Source: [Village Green Apothecary](https://myvillanegreen.com/blogs/post/menopause-hormone-therapy-when-your-heart-is-at-risk-what-the-2026-guidelines-say)